| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President & CEO
1 company
Derek T Chalmers last filed a Form 4 in September 2021, as President & CEO at TVRD. From January 2016 to September 2021, the filings on record show 0 open-market purchases and 37 sales. Derek T Chalmers's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 991,405 shares of TVRD. The TVRD filings lean toward selling, a net 416,442 shares.
Shares as reported in the last Form 4 for each company; the most recent is from September 2021. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2018 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 20,000 | $19.71 | $394,200.00 | -1.9% | |
| Jul 10, 2018 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 20,000 | $20.64 | $412,800.00 | -1.9% | |
| Feb 16, 2018 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 5,400 | $15.00 | $81,000.00 | -0.5% | |
| Jan 24, 2018 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sale+OE | 12,500 | $15.00 | $187,500.00 | -1.2% | |
| Nov 1, 2017 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sale+OE | 16,000 | $12.66 | $202,560.00 | -1.5% | |
| Jul 14, 2017 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sale+OE | 25,000 | $15.05 | $376,250.00 | -2.3% | |
| Jan 6, 2016 | TVRD Tvardi Therapeutics, Inc. | President & CEO | Sell | 12,500 | $17.22 | $215,250.00 | -1.1% |